Font size

Outlook for 2014/2015

Looking beyond the current financial year, we expect broadly favourable conditions in non-life reinsurance and life/health reinsurance.

In non-life reinsurance we anticipate growth in premium volume averaging around 3% to 5%. We are looking to generate an EBIT margin of at least 10%.

In the coming years, as in recent years, organic growth of between 5% and 7% should be attainable in life and health reinsurance. We expect an EBIT margin of at least 6% for the areas of mortality and morbidity business; in financial solutions and longevity business an EBIT margin of at least 2% is anticipated.

The return on investment of 3.4% targeted for 2013 is, however, likely to decrease further in 2014.

Our strategic objective on the Group level is to achieve a return on equity at least 750 basis points above the risk-free interest rate. We also seek to increase both the earnings per share and the book value per share (including dividends paid) by at least 10% annually.


Your last visited pages:


Download this chapter as a PDF file:

Topic Navigation

Build your own individual report according to the topics you are interested in. Choose the topics which are essential for you.

show all

My Annual Report

Your page has been added successfully. Please click on "My Annual Report" in the service section to see your selection.

Link für Popup